Brand Name: PALACOS Product Name: PALACOS R pro 40; PALACOS R pro 80 Model/Catalog Number: 5081...
FDA Device Recall #Z-1080-2026 - Class II, December 9, 2025
Recall Summary
| Recall Number | Z-1080-2026 |
| Classification | Class II - Moderate risk |
| Date Initiated | December 9, 2025 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Heraeus Medical GmbH (Dental Division) |
| Location | Wehrheim |
| Product Type | Devices |
Product Description
Brand Name: PALACOS Product Name: PALACOS R pro 40; PALACOS R pro 80 Model/Catalog Number: 5081286; 5081287 Software Version: N/A Product Description: Radiopaque, poly(methyl methacrylate)-based (PMMA) bone cement, pre-filled into a mixing and application system, suitable for use with or without vacuum (ready to mix). Component: N/A
Reason for Recall
increase of complaints regarding the breakage of the ampoules within their device systems. An extensive investigation revealed that multiple factors have an impact on the ampoule breakage. An unfortunate combination of these influence factors can lead to unbreakable ampoules. If none or not all ampoules break, the product cannot be used on the patient since no or no appropriate cement dough is formed.
Distribution Pattern
International distribution in the countries of Aland Islands, Australia, Belgium, Denmark, Finland, Germany, Ireland, Italy, Liechtenstein, Netherlands, New Zealand, Norway, Portugal, Spain, Sweden, Switzerland, United Kingdom.
Lot / Code Information
Lot Code: UDI-DI: 04260102136120; 04260102136151
Other Recalls from Heraeus Medical GmbH (Dental Division)
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1997-2026 | Class III | Heraeus, PALAMIX uno. Material Number: 66057893. | Mar 25, 2026 |
| Z-1998-2026 | Class III | Heraeus, PALAMIX duo. Material Number: 66057897. | Mar 25, 2026 |
| Z-1081-2026 | Class II | Brand Name: PALACOS Product Name: PALACOS R+G ... | Dec 9, 2025 |
| Z-1083-2026 | Class II | Brand Name: PALACOS Product Name: PALACOS MV p... | Dec 9, 2025 |
| Z-1082-2026 | Class II | Brand Name: PALACOS Product Name: PALACOS MV+G... | Dec 9, 2025 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic, removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency, Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.